Impact of Sunitinib on Human Thyroid Cancer Cells

Background/Aims: Thyroid cancer accounts for about 1% of all cancer cases. Multikinase inhibitors like sunitinib (S) have a promising potential in thyroid cancer therapy. Therefore, the principal aim of this study was to investigate the impact of sunitinib on the secretion of cytokines of follicular...

Full description

Bibliographic Details
Main Authors: Jirka Grosse, Elisabeth Warnke, Fabian Pohl, Nils E. Magnusson, Markus Wehland, Manfred Infanger, Christoph Eilles, Daniela Grimm
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2013-07-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/350132